News

New trial to test whether quit-smoking medication works to help people to quit vaping.

MUSC researchers have engineered a new type of genetically modified immune cell that could help organ transplant patients who are prone to rejection.

Many people remain unaware that HPV can cause six types of cancer – and that can affect whether people choose to vaccinate.

Counties with historically lower rates of screening for cervical cancer have higher rates of late-stage diagnosis and death.

An MUSC study lays the scientific groundwork for a new approach to preventing compromised kidney function and kidney failure in patients with lupus.

A new modeling study provides insight for guideline-writing bodies on who should be screened for anal cancer, how often and with which method.

With $26.5 million in new funding, SCTR will clear the way for the translation of research breakthroughs into clinics and communities.

Understanding who is using the latest nicotine product – oral nicotine pouches – is the key to developing future research on the pouches' effects.

Anthony Cannella has always been willing to try the newest treatments for lymphoma. So he readily agreed to sign up for a CAR-T clinical trial at Hollings.

Children who do not meet inclusion criteria for current peds studies now have a chance through an innovative program.